• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Canada
  • United Kingdom
  • Subscribe
  • facebook
  • instagram
  • RSS
  • RSMUS.com

The Real Economy Blog

Search

  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences

Matt Wolf, Director, Health Care Senior Analyst

@MattWolfHC

Matt leads RSM’s health care valuation consulting group. In this capacity, Matt helps health care clients evaluate mergers, acquisitions, joint ventures, and other growth strategies.

In January 2018, Matt was selected as a senior analyst RSM’s cutting edge Industry Eminence Program, which positions its senior analysts to understand, forecast and communicate economic, business and technology trends shaping the industries RSM serves. These senior analysts advise clients on conditions impacting middle market leaders. Matt’s focus is the health care and life sciences space.

When addressing nursing shortage, look to your own ranks first

Aug. 2, 2019 by Matt Wolf

The market for skilled workers, administrators and support staff remains tight in U.S. health care as providers struggle to fill jobs, particularly critical roles such as nurses. The numbers have not appreciably improved since the last time I wrote about this topic: Total health care job openings have remained around 1.1 million to 1.2 million since December ... READ MORE >

Want a fuller picture of biotech’s promise? Look beyond the public markets

Jun. 19, 2019 by Matt Wolf

A recent Wall Street Journal article highlights the underperformance of the Nasdaq Biotech Index against other benchmarks. The article implies the weak returns are due to a lack of blockbuster biotech therapies; at the same time, the piece underscores the robust private funding activity within the biotech ecosystem. The ecosystem and the capital markets in ... READ MORE >

IMF cuts global growth outlook to lowest since 2009

May. 21, 2019 by Matt Wolf

IMF Chart 1

The International Monetary Fund recently revised downward its forecast for global growth to 3.3 percent from 3.5 percent, the lowest level since 2009. Business executives, advisors, and other leaders must understand the fundamental changes that informed the revision and how those changes may impact their organizations. Before we dig in to the report ... READ MORE >

Biotech needs cash in hesitant market

Apr. 3, 2019 by Matt Wolf

biotech stock volatility chart

Life science companies require a cash infusion at least twice as big as that of 2018 to fund research and development at a time when investors remain skittish, according to a Bloomberg analysis. The analysis suggests that over 100 biotech companies, including makers of oncology therapies and treatments for other life-threatening conditions, need to raise ... READ MORE >

Apple Heart Study should not dampen industry view of health tech

Mar. 19, 2019 by Matt Wolf

On March 16, Stanford researchers released results from the Apple Heart Study; this significant research project relied on data gleaned from some 420,000 adult Americans who agreed to wear an Apple Watch that monitored their cardiac rhythms to identify irregularities. The study, which used an iPhone app to enroll participants, left observers questioning ... READ MORE >

Health care adds 38,600 Jobs in February, but is that enough?

Mar. 6, 2019 by Matt Wolf

Recent employment releases, while generally positive, belie a systemic problem in the health care labor market: How will health systems, payers and other providers possibly find enough of the right people to deliver the care their patients expect? ADP released its February jobs report earlier on Wednesday. Health care services, which include providers, ... READ MORE >

Better data use has pros and cons for life sciences

Dec. 13, 2018 by Matt Wolf

Life science graphic

The volume and variety of health care data should expand significantly in 2019. Specifically, we will be monitoring growth in data sources outside those collected from traditional electronic health records, including information gleaned from wearable technology and direct-to-consumer genetic testing. Life science companies should consider how best to ... READ MORE >

Medicaid expansion to lift health care in 2019

Dec. 13, 2018 by Matt Wolf and Rick Kes

Hospital hallway

Four states—Idaho, Nebraska, Utah and Montana— included Medicaid expansion on their ballots in 2018’s midterm elections. Montana’s ballot item was a renewal of expansion, which failed; the three other states saw Medicaid expansion initiatives pass, and we expect health care providers in those states to benefit in 2019. In addition, a few states saw party ... READ MORE >

« Previous Page

Primary Sidebar

Other Regions

  • Canada
  • United Kingdom

Categories

  • Economics
  • Technology
  • Consumer Products
  • Industrials
  • Financial Services
  • Real Estate
  • Health Care
  • Life Sciences

RSMUS.com links

The Real Economy

Middle Market Business Index

MMBI Special Reports

Footer

  • Facebook
  • Instagram
  • RSS

About The Real Economy Blog

The Real Economy Blog from RSM US LLP was developed to provide timely economic insights about the middle market economy. It is offered as a complement to RSM’s macroeconomic thought leadership, including The Real Economy monthly publication and the proprietary RSM US Middle Market Business Index (MMBI).

© 2021 RSMUS.com | Privacy Policy | Cookie Policy

The Real Economy Blog
  • Economics
  • Technology
  • Consumer
  • Industrials
  • Finance
  • Real Estate
  • Health Care
  • Life Sciences